ARS Pharmaceuticals Inc
NASDAQ:SPRY

Watchlist Manager
ARS Pharmaceuticals Inc Logo
ARS Pharmaceuticals Inc
NASDAQ:SPRY
Watchlist
Price: 18.21 USD 1.9% Market Closed
Market Cap: 1.8B USD

Relative Value

The Relative Value of one SPRY stock under the Base Case scenario is hidden USD. Compared to the current market price of 18.21 USD, ARS Pharmaceuticals Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SPRY Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
42
vs Industry
6
Median 3Y
458.6
Median 5Y
14.3
Industry
7.5
Forward
22
vs History
vs Industry
Median 3Y
-18.9
Median 5Y
-18.8
Industry
23.6
Forward
-12.1
vs History
vs Industry
Median 3Y
-17.1
Median 5Y
-16.8
Industry
20.2
vs History
vs Industry
Median 3Y
-14.9
Median 5Y
-14.9
Industry
22.9
vs History
0
vs Industry
15
Median 3Y
2.9
Median 5Y
2.7
Industry
2.8
vs History
42
vs Industry
5
Median 3Y
261.2
Median 5Y
10.8
Industry
7.7
Forward
18.6
vs History
5
vs Industry
3
Median 3Y
0
Median 5Y
0
Industry
9.6
vs History
vs Industry
Median 3Y
-11.9
Median 5Y
-10.9
Industry
4.9
Forward
-10.1
vs History
vs Industry
Median 3Y
-11.9
Median 5Y
-11.9
Industry
4.9
Forward
-10.1
vs History
vs Industry
Median 3Y
-11.3
Median 5Y
-10.7
Industry
5.4
vs History
vs Industry
Median 3Y
-11.3
Median 5Y
-10.7
Industry
4
vs History
52
vs Industry
0
Median 3Y
43.4
Median 5Y
43.4
Industry
5.1

Multiples Across Competitors

SPRY Competitors Multiples
ARS Pharmaceuticals Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
ARS Pharmaceuticals Inc
NASDAQ:SPRY
1.8B USD 18.4 -114.2 -56.6 -55.8
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 182 884.2 -162 466.2 -197 285.8 -195 034.5
US
Abbvie Inc
NYSE:ABBV
338B USD 5.9 81.4 15.5 22.9
US
Amgen Inc
NASDAQ:AMGN
160B USD 4.7 27 14.5 23.8
US
Gilead Sciences Inc
NASDAQ:GILD
135.5B USD 4.7 22.7 9.9 13.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.2B USD 10.7 -120.6 25.7 26.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 060.9 -525.9 -572.7 -557.4
AU
CSL Ltd
ASX:CSL
120.3B AUD 5.2 28.6 17.6 22
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
59.4B USD 4.2 13.2 11.8 13.2
US
Seagen Inc
F:SGT
39.3B EUR 19.9 -60.9 -65.6 -59.2
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
42B USD 17.9 -155.8 -699 -350.3
P/S Multiple
Revenue Growth P/S to Growth
US
ARS Pharmaceuticals Inc
NASDAQ:SPRY
Average P/S: 3 107 730.6
18.4
61%
0.3
FR
Pharnext SCA
OTC:PNEXF
34 182 884.2
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.9
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.7
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.7
10%
1.1
US
E
Epizyme Inc
F:EPE
2 060.9
N/A N/A
AU
CSL Ltd
ASX:CSL
5.2
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.2
4%
1.1
US
S
Seagen Inc
F:SGT
19.9
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.9
30%
0.6
P/E Multiple
Earnings Growth PEG
US
ARS Pharmaceuticals Inc
NASDAQ:SPRY
Average P/E: 34.6
Negative Multiple: -114.2
62%
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 466.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.4
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
27
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.7
189%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -120.6 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -525.9 N/A N/A
AU
CSL Ltd
ASX:CSL
28.6
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -155.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
ARS Pharmaceuticals Inc
NASDAQ:SPRY
Average EV/EBITDA: 15.8
Negative Multiple: -56.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 285.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.5
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.5
17%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
6%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.7
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -572.7 N/A N/A
AU
CSL Ltd
ASX:CSL
17.6
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.8
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -699 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
ARS Pharmaceuticals Inc
NASDAQ:SPRY
Average EV/EBIT: 20.4
Negative Multiple: -55.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 034.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.9
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.8
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.6
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.9
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -557.4 N/A N/A
AU
CSL Ltd
ASX:CSL
22
14%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.2 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -350.3 N/A N/A